These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 6231047

  • 1. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N, Russell N, Ganeshaguru K, Jackson BF, Piga A, Prentice HG, Foa R, Hoffbrand AV.
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [Abstract] [Full Text] [Related]

  • 2. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD, Ganeshaguru K, Knauf W, Dietz G, Trede I, Hoffbrand AV, Hunstein W.
    Leuk Res; 1989 Jan; 13(4):269-78. PubMed ID: 2785618
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS, Hershfield MS.
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [Abstract] [Full Text] [Related]

  • 4. The biochemical and clinical consequences of 2'-deoxycoformycin in T cell chronic lymphocytic leukaemia.
    Hallam LJ, Van der Weyden MB, Ackland SP, Bagnara AS, Whiteside MG.
    Scand J Haematol; 1984 Jan; 32(1):55-64. PubMed ID: 6607510
    [Abstract] [Full Text] [Related]

  • 5. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

  • 6. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
    Ruers TJ, Buurman WA, van der Linden CJ.
    J Immunol; 1987 Jan 01; 138(1):116-22. PubMed ID: 3097141
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A, Simmonds HA, Morris GS, Fairbanks LD.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3561-9. PubMed ID: 3876835
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ, Hallam LJ, Jack I, Van Der Weyden MB.
    J Lab Clin Med; 1984 Jul 01; 104(1):86-95. PubMed ID: 6330251
    [Abstract] [Full Text] [Related]

  • 13. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD, Ip H, Pereira S.
    Clin Exp Immunol; 1982 Dec 01; 50(3):587-95. PubMed ID: 6299634
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S, Carrera CJ, Kubota M, Wasson DB, Carson DA.
    J Clin Invest; 1985 Feb 01; 75(2):377-83. PubMed ID: 2579098
    [Abstract] [Full Text] [Related]

  • 16. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS, Kredich NM, Koller CA, Mitchell BS, Kurtzberg J, Kinney TR, Falletta JM.
    Cancer Res; 1983 Jul 01; 43(7):3451-8. PubMed ID: 6601986
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT, Dunne JV, Yang WC.
    Blood; 1982 Oct 01; 60(4):872-6. PubMed ID: 6981441
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D, Bluestein HG, Thompson L, Seegmiller JE.
    Cell Immunol; 1984 Jul 01; 86(2):510-7. PubMed ID: 6610485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.